Trials / Unknown
UnknownNCT04038749
Satisfaction of Patients With the Chosen Method of Inhibition of Lactation
Satisfaction of Patients With the Chosen Method of Inhibition of Lactation: With the Use of Drugs Lowering the Level of Prolactin or Without the Use of Pharmacological Agents in Postnatal Period, Taking Into Account Individual Conditions
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Żelazna Medical Centre, LLC · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to improve the standard of care in case of the inhibition of lactation. The participant qualified for the study will answer the questions contained in the survey. The patient will have her breast palpated and then will be instructed on the possible options for the inhibition of lactation. The participant, who decides to inhibit lactation with medications, will be consulted by a doctor. Each patient will receive information of the possible ways to relieve the symptoms of overfilled breast and be able to contact with lactation consultant. The participant will also receive a card to assess the severity of symptoms in the following days. The investigators will call the patient between the third and fifth day by phone. Once again, after 2 weeks from the beginning of the inhibition of lactation in order to ask questions contained in the survey (the course of the process, problems that occurred and the level of satisfaction with the chosen method).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bromocriptine | Bromocriptine - on the first day of treatment (1,25 mg) with morning and evening meal and then 2,5 mg dose twice a day for two weeks (14 days) |
| DRUG | Cabergoline | Cabergoline - one dose (1 mg) on the first day after childbirth or 0.25 mg dose every 12 hours for 2 days |
| OTHER | Natural methods | milk expression, cold compress, cabbage leaf compresses, mild painkiller- e.g. ibuprofen, supportive bra, sage tea. |
Timeline
- Start date
- 2019-06-16
- Primary completion
- 2022-07-01
- Completion
- 2022-12-31
- First posted
- 2019-07-31
- Last updated
- 2019-07-31
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT04038749. Inclusion in this directory is not an endorsement.